These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 4795753)

  • 1. Enhanced locomotor activity following amphetamine in mouse-killing rats.
    Salama AI; Goldberg ME
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):162-9. PubMed ID: 4795753
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine.
    Peterson DW; Sparber SB
    J Pharmacol Exp Ther; 1974 Dec; 191(3):349-57. PubMed ID: 4427285
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral depression and its neurochemical correlates at high doses of d-amphetamine in rats.
    Copeland RL; Aulakh CS; Bhattacharyya AK; Pradhan SN
    Neuropharmacology; 1980 Oct; 19(10):1027-30. PubMed ID: 7191484
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the effects of D-amphetamine and L-amphetamine in reversing depression of mouse locomotor activity caused by reserpine.
    Proctor CD; Kirby J; Wood MH; Wade LH; King PK
    Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):108-15. PubMed ID: 4451411
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple daily amphetamine administration: behavioral and neurochemical alterations.
    Segal DS; Weinberger SB; Cahill J; McCunney SJ
    Science; 1980 Feb; 207(4433):905-7. PubMed ID: 7188815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the aggressiveness-stereotypy complex induced in mice by amphetamine or D,L-dopa. II.
    Roliński Z
    Pol J Pharmacol Pharm; 1974; 26(3):369-78. PubMed ID: 4277363
    [No Abstract]   [Full Text] [Related]  

  • 7. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 8. Various effects of d-amphetamine in rats with selective lesions of brain noradrenaline - containing neurons or treated with penfluridol.
    Quattrone A; Bendotti C; Recchia M; Samanin R
    Commun Psychopharmacol; 1977; 1(6):525-31. PubMed ID: 564765
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparative study of d- and l-amphetamine on the open field performance of rats.
    Dandiya PC; Kulkarni SK
    Psychopharmacologia; 1974; 39(1):67-70. PubMed ID: 4472934
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of d-amphetamine sulfate given to pregnant mice on activity and on catecholamines in the brains of offspring.
    Middaugh LD; Blackwell LA; Santos CA; Zemp JW
    Dev Psychobiol; 1974 Sep; 7(5):429-38. PubMed ID: 4426470
    [No Abstract]   [Full Text] [Related]  

  • 12. Amphetamine reduction of motor activity in rats after neonatal administration of 6-hydroxydopamine.
    Sorenson CA; Vayer JS; Goldberg CS
    Biol Psychiatry; 1977 Feb; 12(1):133-7. PubMed ID: 836921
    [No Abstract]   [Full Text] [Related]  

  • 13. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of amphetamine on electroshock responses in developing rats.
    Vernadakis A; Robb D
    Dev Psychobiol; 1974 Jan; 7(1):89-95. PubMed ID: 4812273
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

  • 16. Behavioral and neurochemical correlates of repeated d-amphetamine administration.
    Segal DS
    Adv Biochem Psychopharmacol; 1975; 13():247-62. PubMed ID: 1171583
    [No Abstract]   [Full Text] [Related]  

  • 17. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 18. Regional norepinephrine response to amphetamine using dialysis: comparison with caudate dopamine.
    Kuczenski R; Segal DS
    Synapse; 1992 Jun; 11(2):164-9. PubMed ID: 1626314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of d-amphetamine pellet implantation as a model for d-amphetamine tolerance in the mouse.
    Hitzemann RJ; Loh HH; Craves FB; Domino EF
    Psychopharmacologia; 1973 Jun; 30(3):227-40. PubMed ID: 4736782
    [No Abstract]   [Full Text] [Related]  

  • 20. Cats develop tolerance to d-amphetamine's effects upon locomotion and stereotyped behaviors.
    Jacobs BL; Heym J; Trulson ME
    Eur J Pharmacol; 1981 Jan; 69(3):353-6. PubMed ID: 7194184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.